pathwayhealthadmin

Adjusted EBITDA loss improved by 21% from previous quarter to $1.4 million compared to $1.7 million in the previous quarter Entered into a $1.25 million and a $1.0 million secured bridge loan to support general working capital, professional fees and other costs associated with the Arrangement transaction Subsequent to year end, the Company entered into [...]

TORONTO, Ontario – March 31, 2023 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (“Pathway” or the “Corporation”), an integrated healthcare company that provides products and services to patients suffering from chronic pain and related conditions, today announced, further to its news releases dated December 22, 2022 and March 1, 2023, that the Corporation has [...]

TORONTO, Ontario, March 28, 2023 – Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023, February 9, 2023 and February 17, 2023, it has made its third and final draw in the amount of $250,000 (the “Draw Down”) under the $1.25 [...]

TORONTO, ON, March 1, 2023 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (“Pathway” or the “Corporation”) is pleased to provide an update on its proposed acquisition of all the issued and outstanding common shares of each of HEAL Global Holdings Corp. (“HEAL”) and The Newly Institute Inc. (“The Newly”) from their respective shareholders in [...]

TORONTO, Ontario, February 17, 2023 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023 and February 9, 2023, it has made its second draw down in the amount of $500,000 (the “Draw Down”) under the $1.25 million secured [...]

TORONTO, Ontario, February 9, 2023 – Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press release of February 3, 2023, it has elected to draw down $500,000 (the “Draw Down”) under the $1.25 million secured convertible promissory grid note (the “Note”) with HEAL Global Holdings Corp. [...]

Toronto, Ontario, February 3, 2023 – Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce a proposed $1.25 million private placement of a secured convertible promissory note with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company’s largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc. (“ADH”), and which is [...]

TORONTO, ON, December 22, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) (“Pathway” or the “Corporation”) is pleased to announce it has entered into a non-binding letter of intent dated December 16, 2022 (“LOI”) whereby it is proposed that Pathway will acquire all of the issued and outstanding common shares of each of HEAL [...]

Adjusted EBITDA loss improved by 20% from previous quarter to $1.3 million compared to $1.7 million in the previous quarter Entered into a $3.5 million revolving line of credit to support working capital and expansion requirements Expanded services to veterans, RCMP and first responders with the acquisition of the operating assets of IRP Health Ltd. [...]

TORONTO, ON, November 11, 2022 – Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to announce the appointment of MNP LLP as its new auditor effective as of November 10, 2022. MNP LLP (the “Successor Auditor”) replaces Grant Thornton LLP (“Grant Thornton”) (the “Former Auditor”) as Pathway’s auditor. The Board [...]